Abstract
Abstract 165: Study of lobeglitazone for evaluation of safety and efficacy with active comparator pioglitazone in Indian T2DM patients: A randomized phase III trial (sensitize India)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
